Press releases
- Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
- Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
Key statistics
As of last trade Kezar Life Sciences Inc (2KZ:BER) traded at 0.64, 4.07% above its 52-week low of 0.615, set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.64 |
---|---|
High | 0.64 |
Low | 0.64 |
Bid | 0.65 |
Offer | 0.665 |
Previous close | 0.64 |
Average volume | 0.00 |
---|---|
Shares outstanding | 72.80m |
Free float | 62.00m |
P/E (TTM) | -- |
Market cap | 51.83m USD |
EPS (TTM) | -1.40 USD |
Data delayed at least 15 minutes, as of May 29 2024 07:55 BST.
More ▼